Business Standard

Moderna, Thermo Fisher partner to manufacture Covid vaccine, other drugs

Thermo Fisher had already partnered with Moderna last year to help scale up production of its Covid vaccine, branded as Spikevax

Moderna
Premium

Moderna Covid-19 vaccine

Reuters
Moderna Inc has entered into a long-term agreement with Thermo Fisher Scientific for the manufacturing of its Covid-19 vaccine and other experimental medicines based on mRNA technology, the companies said on Wednesday.

Thermo Fisher had already partnered with Moderna last year to help scale up production of its Covid vaccine, branded as Spikevax.

As a part of the 15-year expanded deal, Thermo Fisher would provide dedicated manufacturing capacity in the United States for fill/finish services as well as labeling and packaging services for Spikevax and other mRNA drugs in Moderna's pipeline.

Moderna's vaccine received full US approval in January for adults and is

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 23 2022 | 8:04 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com